STAB

Statera Biopharma, Inc. Common Stock
STAB

Overview Fund Activity
Delisted

STAB was delisted on the 11th of January, 2023.

Back to rankings

25 hedge funds and large institutions have $1.22M invested in Statera Biopharma, Inc. Common Stock in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 8 closing their positions.

Holders
25
Holders Change
-6
Holders Change %
-19.35%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
5
Closed
8
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$2K

Top Buyers

1
Citadel Advisors
1
Citadel Advisors
Florida
$22K
2
Vanguard Group
2
Vanguard Group
Pennsylvania
$662K
3
U
3
UBS
Switzerland
$4K
4
Group One Trading
4
Group One Trading
Illinois
$3K
5
SM
5
Sabby Management
Florida
$404

Top Sellers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$0
2
AW
2
ACG Wealth
Georgia
$0
3
GC
3
Guggenheim Capital
Illinois
$0
4
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$0
5
VCAM
5
Van Cleef Asset Management
Ohio
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
VCAM
26
Van Cleef Asset Management
Ohio
– -$5K -500 Closed
BNP Paribas Financial Markets
27
BNP Paribas Financial Markets
France
– -$393 -41 Closed
1
2